140 related articles for article (PubMed ID: 11710596)
1. Immunohistochemical study on VEGF expression in endometrial carcinoma--comparison with p53 expression, angiogenesis, and tumor histologic grade.
Fujisawa T; Watanabe J; Akaboshi M; Ohno E; Kuramoto H
J Cancer Res Clin Oncol; 2001 Nov; 127(11):668-74. PubMed ID: 11710596
[TBL] [Abstract][Full Text] [Related]
2. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer.
Maeda K; Kang SM; Onoda N; Ogawa M; Sawada T; Nakata B; Kato Y; Chung YS; Sowa M
Oncology; 1998; 55(6):594-9. PubMed ID: 9778629
[TBL] [Abstract][Full Text] [Related]
4. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance].
Liu DB; Chen KN; Cao XZ; Wang T
Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis.
Kang SM; Maeda K; Onoda N; Chung YS; Nakata B; Nishiguchi Y; Sowa M
Int J Cancer; 1997 Oct; 74(5):502-7. PubMed ID: 9355971
[TBL] [Abstract][Full Text] [Related]
6. Clinical prognostic values of vascular endothelial growth factor, microvessel density,and p53 expression in esophageal carcinomas.
Ahn MJ; Jang SJ; Park YW; Choi JH; Oh HS; Lee CB; Paik HK; Park CK
J Korean Med Sci; 2002 Apr; 17(2):201-7. PubMed ID: 11961303
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma.
Yokoyama Y; Sato S; Futagami M; Fukushi Y; Sakamoto T; Umemoto M; Saito Y
Gynecol Oncol; 2000 Jun; 77(3):413-8. PubMed ID: 10831352
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression.
Lee JS; Kim HS; Jung JJ; Lee MC; Park CS
Gynecol Oncol; 2002 Jun; 85(3):469-75. PubMed ID: 12051876
[TBL] [Abstract][Full Text] [Related]
9. Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression.
Faviana P; Boldrini L; Spisni R; Berti P; Galleri D; Biondi R; Camacci T; Materazzi G; Pingitore R; Miccoli P; Fontanini G
Oncol Rep; 2002; 9(3):617-20. PubMed ID: 11956638
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor and p53 protein in association with neovascularization in human malignant gliomas.
Miyagami M; Tazoe M; Nakamura S
Brain Tumor Pathol; 1998; 15(2):95-100. PubMed ID: 10328546
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression.
Lee JS; Kim HS; Jung JJ; Park CS; Lee MC
J Surg Oncol; 2001 May; 77(1):55-60. PubMed ID: 11344484
[TBL] [Abstract][Full Text] [Related]
12. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
[TBL] [Abstract][Full Text] [Related]
14. [p53 and vascular endothelial growth factor expression in astrocytoma and their relation to angiogenesis].
Ye S; Zhong X; Chen Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):326-9. PubMed ID: 11783119
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
[TBL] [Abstract][Full Text] [Related]
16. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
17. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer.
Strohmeyer D; Rössing C; Bauerfeind A; Kaufmann O; Schlechte H; Bartsch G; Loening S
Prostate; 2000 Nov; 45(3):216-24. PubMed ID: 11074523
[TBL] [Abstract][Full Text] [Related]
19. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
